The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 27, 2020
Filed:
Jul. 26, 2019
Applicant:
Concert Pharmaceuticals, Inc., Lexington, MA (US);
Inventors:
Philip B. Graham, Boston, MA (US);
I. Robert Silverman, Arlington, VA (US);
Assignee:
Concert Pharmaceuticals, Inc., Lexington, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/485 (2006.01); C07D 221/28 (2006.01); A61P 25/08 (2006.01); A61P 25/16 (2006.01); A61P 29/00 (2006.01); C07B 59/00 (2006.01); C07D 471/08 (2006.01); A61K 45/06 (2006.01); A61K 31/195 (2006.01); A61K 31/4709 (2006.01);
U.S. Cl.
CPC ...
A61K 31/485 (2013.01); A61K 31/195 (2013.01); A61K 31/4709 (2013.01); A61K 45/06 (2013.01); A61P 25/08 (2018.01); A61P 25/16 (2018.01); A61P 29/00 (2018.01); C07B 59/002 (2013.01); C07D 221/28 (2013.01); C07D 471/08 (2013.01);
Abstract
This invention relates to novel morphinan compounds and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a σreceptor agonist that also has NMDA antagonist activity.